SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Lineage Cell Therapeutics, Inc. (LCTX) News

Follow Lineage Cell Therapeutics, Inc. (LCTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol LCTX Asset equity Sector Markets 90 days 6 Last 0.7838 Updated Nov 16, 2026, 10:04 PM UTC Open live news feed Open LCTX chart & news
M Lineage Cell Therapeutics CFO Jill Ann Howe Acquires $17,100 in Shares EQUITY | Nov 16, 2026, 10:04 PM UTC M Lineage Cell Therapeutics Agrees to Acquire NeuroAirmid for $2.4 Million The biotechnology company agreed to acquire NeuroAirmid Therapeutics for $2.4 million. NeuroAirmid also entered a license agreement with the University of California Regents related to a neural cell therapy program. EQUITY | Nov 12, 2026, 09:57 PM UTC M Lineage Announces Acquisition of NeuroAirmid Therapeutics The acquisition includes a clinical-stage program for the treatment of Huntington's disease. MNA | Nov 12, 2026, 09:20 PM UTC M Lineage Cell Therapeutics to Report Third-Quarter Results November 12 Lineage Cell Therapeutics says it will report third-quarter 2026 financial results and provide a business update on November 12, 2026. EQUITY | Nov 05, 2026, 01:00 PM UTC H Transcript: Lineage Cell Therapeutics Q2 2026 Earnings Conference Call On Thursday, Lineage Cell Therapeutics (AMEX: LCTX ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time acces LIVE | Oct 12, 2026, 11:43 AM UTC L Lineage Cell Therapeutics gets USPTO patent issuance for AlloSCOPE™ platform Lineage Cell Therapeutics said the USPTO has issued a patent underlying its AlloSCOPE™ 5D manufacturing platform. EQUITY | Sep 08, 2026, 12:01 PM UTC H Transcript: Lineage Cell Therapeutics Q1 2026 Earnings Conference Call On Tuesday, Lineage Cell Therapeutics (AMEX: LCTX ) discussed first-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts an EARNINGS | Jul 01, 2026, 08:05 AM UTC